Literature DB >> 10728702

Class A helix-loop-helix proteins are positive regulators of several cyclin-dependent kinase inhibitors' promoter activity and negatively affect cell growth.

A Pagliuca1, P Gallo, P De Luca, L Lania.   

Abstract

The class A of basic helix-loop-helix (bHLH) proteins are ubiquitously expressed transcription factors playing a pivotal role in the regulation of cell growth and differentiation. We determined that enforced expression of all four different mammalian members of this family, E12, E47, E2-2, and HEB, suppresses the cell colony-forming efficiency of several cell lines. To gain insights into the mechanisms by which class A bHLH factors affect cell growth, we have investigated their role in the transcriptional regulation of cyclin-dependent kinase inhibitors. We found that p21CIP1/ WAF1, p15INK4B, and p16INK4B promoter sequences contain E-boxes that render these genes competent for class A bHLH-mediated transcriptional activation and Id-mediated repression. The mechanism underlying the class A bHLH-mediated inhibition of cell growth does not involve an arrest of G1 progression in 293T cells. In fact, contrary to what has been found in 3T3 NIH fibroblasts, we found that enhanced expression of class A bHLH proteins led to a decreased proliferation rate by promoting cell death associated with the induction of apoptosis. These findings highlight the role of the class A bHLH proteins as general negative regulators of cell proliferation through a mechanism(s) that involves both enhancement of several cyclin-dependent kinase inhibitor genes expression and promotion of cell death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10728702

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

1.  Identification of cyclin D3 as a direct target of E2A using DamID.

Authors:  Siyuan Song; Jonathan Cooperman; Danielle L Letting; Gerd A Blobel; John Kim Choi
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

2.  High expression of transcription factor 4 (TCF4) is an independent adverse prognostic factor in acute myeloid leukemia that could guide treatment decisions.

Authors:  Florentien E M in 't Hout; Bert A van der Reijden; Davide Monteferrario; Joop H Jansen; Gerwin Huls
Journal:  Haematologica       Date:  2014-08-22       Impact factor: 9.941

3.  Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.

Authors:  M J Gray; N A Dallas; G Van Buren; L Xia; A D Yang; R J Somcio; P Gaur; L S Mangala; P E Vivas-Mejia; F Fan; A M Sanguino; G E Gallick; G Lopez-Berestein; A K Sood; L M Ellis
Journal:  Oncogene       Date:  2008-09-22       Impact factor: 9.867

4.  A novel E2 box-GATA element modulates Cdc6 transcription during human cells polyploidization.

Authors:  Nuria Vilaboa; Rodrigo Bermejo; Pilar Martinez; Rafael Bornstein; Carmela Calés
Journal:  Nucleic Acids Res       Date:  2004-12-08       Impact factor: 16.971

5.  Phosphorylation Regulates Id2 Degradation and Mediates the Proliferation of Neural Precursor Cells.

Authors:  Jaclyn M Sullivan; Matthew C Havrda; Arminja N Kettenbach; Brenton R Paolella; Zhonghua Zhang; Scott A Gerber; Mark A Israel
Journal:  Stem Cells       Date:  2016-02-01       Impact factor: 6.277

6.  Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F.

Authors:  Silvia Coma; Dhara N Amin; Akio Shimizu; Anna Lasorella; Antonio Iavarone; Michael Klagsbrun
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

Review 7.  The ID proteins: master regulators of cancer stem cells and tumour aggressiveness.

Authors:  Anna Lasorella; Robert Benezra; Antonio Iavarone
Journal:  Nat Rev Cancer       Date:  2014-01-20       Impact factor: 60.716

8.  Id3 upregulates BrdU incorporation associated with a DNA damage response, not replication, in human pancreatic β-cells.

Authors:  Seung-Hee Lee; Ergeng Hao; Fred Levine; Pamela Itkin-Ansari
Journal:  Islets       Date:  2011-11-01       Impact factor: 2.694

9.  Id1 immortalizes hematopoietic progenitors in vitro and promotes a myeloproliferative disease in vivo.

Authors:  H C Suh; W Leeanansaksiri; M Ji; K D Klarmann; K Renn; J Gooya; D Smith; I McNiece; S Lugthart; P J M Valk; R Delwel; J R Keller
Journal:  Oncogene       Date:  2008-06-09       Impact factor: 9.867

10.  Genomic loci modulating the retinal transcriptome in wound healing.

Authors:  Félix R Vázquez-Chona; Lu Lu; Robert W Williams; Eldon E Geisert
Journal:  Gene Regul Syst Bio       Date:  2008-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.